Gilead Sciences Inc (GILD)
92.57
+1.48
(+1.62%)
USD |
NASDAQ |
Dec 20, 16:00
92.57
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Market Cap: 115.37B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc | 149.38B |
| Eli Lilly and Co | 728.85B |
| Merck & Co Inc | 248.03B |
| AbbVie Inc | 310.27B |
| Amgen Inc | 141.58B |
Market Cap Related Metrics
| PE Ratio | 1028.56 |
| PS Ratio | 4.095 |
| Price to Book Value | 6.245 |
| Price to Free Cash Flow | 12.29 |
| Price | 92.57 |
| Earnings Yield | 0.10% |
| Operating PE Ratio | 15.16 |
| Normalized PE Ratio | 20.66 |